NNYVMS CE Event: For Feline Diabetes, It’s a Whole New Game
Malone Golf Course
79 Golf Course RoadMalone, NY 12953
United States
Event Details
Presented by: Tina Sung, MA, VMD
This diabetes story focuses on the kidneys. After a quick review of the unique characteristics of feline diabetes mellitus and the associated risk factors, the course will introduce a new once-daily oral treatment for diabetic cats. A member of a new class of drugs called sodium-glucose cotransporter2 (SGLT2) inhibitors, velogliflozin exerts its action in the kidneys to increase excretion of glucose in the urine and lower blood glucose levels. The course will cover safety and effectiveness results from a pivotal field study to demonstrate how this medication will dramatically improve life for diabetic cats, their owners, and veterinarians.
Learning Objectives:
- Review the distinct characteristics of feline diabetes.
- Understand the mode of action of sodium-glucose cotransporter 2 (SGLT2)-inhibitors.
- Explore the effectiveness and safety data behind velagliflozin, the first once-daily oral liquid solution for feline diabetes.
- Learn about the features and benefits of velagliflozin.
Agenda
| April 24 | |
| 5:00 PM | Registration |
| 5:30 PM - 7:00 PM | Dinner |
| 6:00 PM - 8:15 PM | Lecture |
For More Information:
Dr. Tina Sung graduated from the University of Pennsylvania School of Veterinary Medicine. She practiced as a small animal clinician for 10+ years in the Philadelphia area prior to transitioning to industry. She has a special interest in feline medicine, internal medicine and low stress handling. In her current role as a Boehringer-Ingelheim Field Veterinarian, Dr. Sung enjoys meeting with hospital teams and both providing education and learning from her colleagues. In her spare time, she enjoys traveling, running, and dining out.
Lecture generously sponsored by:
